AU2001264078A1 - Thiazolidinedione salt for treatment of diabetes mellitus - Google Patents

Thiazolidinedione salt for treatment of diabetes mellitus

Info

Publication number
AU2001264078A1
AU2001264078A1 AU2001264078A AU6407801A AU2001264078A1 AU 2001264078 A1 AU2001264078 A1 AU 2001264078A1 AU 2001264078 A AU2001264078 A AU 2001264078A AU 6407801 A AU6407801 A AU 6407801A AU 2001264078 A1 AU2001264078 A1 AU 2001264078A1
Authority
AU
Australia
Prior art keywords
hydrobromide
solvate
ethoxy
amino
benzyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001264078A
Other languages
English (en)
Inventor
Ting Chien
Andrew Simon Craig
Tim Chien Ting Ho
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Publication of AU2001264078A1 publication Critical patent/AU2001264078A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
AU2001264078A 2000-06-08 2001-06-08 Thiazolidinedione salt for treatment of diabetes mellitus Abandoned AU2001264078A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0014006.1A GB0014006D0 (en) 2000-06-08 2000-06-08 Novel pharmaceutical
GB0014006 2000-06-08
PCT/GB2001/002567 WO2001094344A1 (en) 2000-06-08 2001-06-08 Thiazolidinedione salt for treatment of diabetes mellitus

Publications (1)

Publication Number Publication Date
AU2001264078A1 true AU2001264078A1 (en) 2001-12-17

Family

ID=9893257

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001264078A Abandoned AU2001264078A1 (en) 2000-06-08 2001-06-08 Thiazolidinedione salt for treatment of diabetes mellitus

Country Status (23)

Country Link
EP (1) EP1296980A1 (no)
JP (1) JP2003535862A (no)
KR (1) KR20030007918A (no)
CN (1) CN1443186A (no)
AP (1) AP2002002673A0 (no)
AU (1) AU2001264078A1 (no)
BG (1) BG107357A (no)
BR (1) BR0111536A (no)
CA (1) CA2411065A1 (no)
CZ (1) CZ20023966A3 (no)
DZ (1) DZ3382A1 (no)
EA (1) EA200300005A1 (no)
GB (1) GB0014006D0 (no)
HU (1) HUP0301137A3 (no)
IL (1) IL153279A0 (no)
MA (1) MA25753A1 (no)
MX (1) MXPA02012100A (no)
NO (1) NO20025883L (no)
OA (1) OA12284A (no)
PL (1) PL360592A1 (no)
SK (1) SK17142002A3 (no)
WO (1) WO2001094344A1 (no)
ZA (1) ZA200209954B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE39384E1 (en) 1993-09-01 2006-11-07 Smithkline Beecham P.L.C. Substituted thiazolidinedione derivatives
DE102005034406A1 (de) * 2005-07-22 2007-02-01 Ratiopharm Gmbh Neue Salze von Rosiglitazon
EP2016076A2 (en) * 2007-01-22 2009-01-21 Teva Pharmaceutical Industries Ltd. Polymorphic forms of rosiglitazone hydrobromide and processes for preparation thereof
EP1956018A1 (de) * 2007-02-06 2008-08-13 Boehringer Ingelheim Pharma GmbH & Co. KG Verfahren zur Herstellung eines Benzimidazolderivats
US20100056583A1 (en) * 2008-08-21 2010-03-04 Teva Pharmaceutical Industries Ltd. Polymorphic forms of rosiglitazone hydrobromide and processes for their preparation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds

Also Published As

Publication number Publication date
SK17142002A3 (sk) 2003-10-07
OA12284A (en) 2003-11-10
HUP0301137A3 (en) 2005-04-28
JP2003535862A (ja) 2003-12-02
BR0111536A (pt) 2003-07-01
CZ20023966A3 (cs) 2003-04-16
ZA200209954B (en) 2003-10-10
MXPA02012100A (es) 2003-04-25
PL360592A1 (en) 2004-09-20
KR20030007918A (ko) 2003-01-23
BG107357A (bg) 2003-08-29
DZ3382A1 (fr) 2001-12-13
EP1296980A1 (en) 2003-04-02
CA2411065A1 (en) 2001-12-13
WO2001094344A1 (en) 2001-12-13
GB0014006D0 (en) 2000-08-02
HUP0301137A2 (hu) 2003-08-28
NO20025883D0 (no) 2002-12-06
MA25753A1 (fr) 2003-04-01
AP2002002673A0 (en) 2002-12-31
NO20025883L (no) 2003-02-03
CN1443186A (zh) 2003-09-17
EA200300005A1 (ru) 2003-04-24
IL153279A0 (en) 2003-07-06

Similar Documents

Publication Publication Date Title
EP1305312B1 (en) Tartrate salts of thiazolidinedione derivative
EP1349855A1 (en) 5-'4-'2-(n-methyl-n- (2-pyridyl)amino)ethoxy!benzyl!thiazolidine-2, 4-dione mesylate salt
AU2001264078A1 (en) Thiazolidinedione salt for treatment of diabetes mellitus
CA2421213A1 (en) The hydrochloride salt of 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione
EP1305311B1 (en) Tartrate salt of thiazolidinedione derivative
EP1446404A1 (en) Rosiglitazone edisylates and their use as antidiabetics
EP1315721A1 (en) A thiazolidinedione derivative and its use as antidiabetic
AU2001262550B2 (en) 5-(4-(2-(n-methyl-n-(2-pyridyl)amino)ethoxy)benzyl)thiazolidine-2,4-dione hydriodide as pharmaceutical
WO2002020520A1 (en) A thiazolidinedione derivative and its use as antidiabetic
EP1305310B1 (en) Tartrate salts of thiazolidinedione derivative
AU2001292034B2 (en) A thiazolidinedione derivative and its use as antidiabetic
US20030162815A1 (en) Thiazolidinedione salt for treatment of diabetes mellitus
AU2001262550A1 (en) 5-(4-(2-(n-methyl-n-(2-pyridyl)amino)ethoxy)benzyl)thiazolidine-2,4-dione hydriodide as pharmaceutical
AU2001292034A1 (en) A thiazolidinedione derivative and its use as antidiabetic